{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:08:35Z","timestamp":1759334915349,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jaad.2017.07.059","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T09:42:51Z","timestamp":1515750171000},"page":"419-421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predicting the incidence and timing of central nervous system disease in metastatic melanoma: Implications for surveillance and preventative therapy"],"prefix":"10.1016","volume":"78","author":[{"given":"Gary B.","family":"Deutsch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Tyrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Yost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariel B.","family":"Deutsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garni","family":"Barkhoudarian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel F.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark B.","family":"Faries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaad.2017.07.059_bib1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11060-014-1533-z","article-title":"Incidence and characteristics of melanoma brain metastases developing during treatment with vemurafenib","volume":"120","author":"Peuvrel","year":"2014","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.jaad.2017.07.059_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3171\/jns.1998.88.1.0011","article-title":"Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma","volume":"88","author":"Sampson","year":"1998","journal-title":"J Neurosurg"},{"issue":"6","key":"10.1016\/j.jaad.2017.07.059_bib3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/DAD.0b013e31827e8315AD","article-title":"Angiotropism in primary cutaneous melanoma with brain metastasis: a study of 20 cases","volume":"35","author":"Hung","year":"2013","journal-title":"Am J Dermatopathol"},{"issue":"10","key":"10.1016\/j.jaad.2017.07.059_bib4","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1002\/cncr.23895","article-title":"Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 cases","volume":"113","author":"Chen","year":"2008","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.jaad.2017.07.059_bib5","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/neuonc\/nos113","article-title":"Challenging the current\u00a0paradigm of melanoma progression: brain metastasis as isolated first visceral site","volume":"14","author":"Ma","year":"2012","journal-title":"Neuro Oncol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217323034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217323034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:46:08Z","timestamp":1759272368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962217323034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0190962217323034"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2017.07.059","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting the incidence and timing of central nervous system disease in metastatic melanoma: Implications for surveillance and preventative therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2017.07.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}